23007-97-8 Usage
Derivative of phenylpropanoid
The compound is derived from phenylpropanoid, which is a class of compounds that includes many important natural products.
Bromine atom attached to phenyl ring
The compound contains a bromine atom that is attached to a phenyl ring, which can affect its chemical properties and reactivity.
Hydroxyl and carboxylic acid groups
The compound contains both a hydroxyl (-OH) and a carboxylic acid (-COOH) functional groups, which contribute to its chemical properties and reactivity.
Used in organic synthesis and drug development
The compound is commonly used in organic synthesis and drug development due to its structural characteristics and functional groups.
Potential applications in medicine
The compound may have potential applications in the field of medicine due to its structural characteristics and functional groups.
Of interest to researchers and industries
The compound's properties and reactivity make it of interest to researchers and industries looking to develop new pharmaceuticals and chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 23007-97-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,0,0 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 23007-97:
(7*2)+(6*3)+(5*0)+(4*0)+(3*7)+(2*9)+(1*7)=78
78 % 10 = 8
So 23007-97-8 is a valid CAS Registry Number.
23007-97-8Relevant academic research and scientific papers
CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS
-
, (2018/05/27)
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds are antagonists to αv- containing integrins. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with dysregulation of av-containing integrins, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.
